Clinical trial
Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of…
NCT00253955 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00253955 |
|---|---|
| Title | Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia |
| Official title | An Open-Label, Multicenter, Multinational, Centrally Randomized, Two-Arm Parallel-Group Study to Demonstrate the Non-Inferiority in Clinical Efficacy of Levofloxacin 750mg od in Comparison With Piperacillin/Tazobactam 4g/500mg Every 8 Hours in the Treatment of Mild to Moderate Hospital-Acquired… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | Levofloxacin, Piperacillin/Tazobactam |
| Enrollment | 460 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Nov 15, 2005 |
| Last update posted | Nov 10, 2008 |
| Countries | Austria, Belgium, Czechia, France, Germany, Greece, Guatemala, Italy, Lebanon, Mexico, Netherlands, Romania and 5 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: